Report cover image

Global Apremilast Tablets Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 199 Pages
SKU # APRC20282816

Description

Summary

According to APO Research, The global Apremilast Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Apremilast Tablets include CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals and Amgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apremilast Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Apremilast Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Apremilast Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apremilast Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Apremilast Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Apremilast Tablets sales, projected growth trends, production technology, application and end-user industry.

Apremilast Tablets Segment by Company

CSPC Ouyi Pharmaceutical
Shanghai Modern Pharmaceutical
Qilu Pharmaceutical
Glenmark Pharmaceuticals
Amgen
Apremilast Tablets Segment by Type

10mg/Tablet
20mg/Tablet
30mg/Tablet
Apremilast Tablets Segment by Application

Hospital Pharmacy
Retail Pharmacy
Apremilast Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apremilast Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apremilast Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apremilast Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Apremilast Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Apremilast Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apremilast Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Apremilast Tablets Market by Type
1.2.1 Global Apremilast Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 10mg/Tablet
1.2.3 20mg/Tablet
1.2.4 30mg/Tablet
1.3 Apremilast Tablets Market by Application
1.3.1 Global Apremilast Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Apremilast Tablets Market Dynamics
2.1 Apremilast Tablets Industry Trends
2.2 Apremilast Tablets Industry Drivers
2.3 Apremilast Tablets Industry Opportunities and Challenges
2.4 Apremilast Tablets Industry Restraints
3 Global Market Growth Prospects
3.1 Global Apremilast Tablets Revenue Estimates and Forecasts (2020-2031)
3.2 Global Apremilast Tablets Revenue by Region
3.2.1 Global Apremilast Tablets Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Apremilast Tablets Revenue by Region (2020-2025)
3.2.3 Global Apremilast Tablets Revenue by Region (2026-2031)
3.2.4 Global Apremilast Tablets Revenue Market Share by Region (2020-2031)
3.3 Global Apremilast Tablets Sales Estimates and Forecasts 2020-2031
3.4 Global Apremilast Tablets Sales by Region
3.4.1 Global Apremilast Tablets Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Apremilast Tablets Sales by Region (2020-2025)
3.4.3 Global Apremilast Tablets Sales by Region (2026-2031)
3.4.4 Global Apremilast Tablets Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Apremilast Tablets Revenue by Manufacturers
4.1.1 Global Apremilast Tablets Revenue by Manufacturers (2020-2025)
4.1.2 Global Apremilast Tablets Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Apremilast Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Apremilast Tablets Sales by Manufacturers
4.2.1 Global Apremilast Tablets Sales by Manufacturers (2020-2025)
4.2.2 Global Apremilast Tablets Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Apremilast Tablets Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Apremilast Tablets Sales Price by Manufacturers (2020-2025)
4.4 Global Apremilast Tablets Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Apremilast Tablets Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Apremilast Tablets Manufacturers, Product Type & Application
4.7 Global Apremilast Tablets Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Apremilast Tablets Market CR5 and HHI
4.8.2 2024 Apremilast Tablets Tier 1, Tier 2, and Tier 3
5 Apremilast Tablets Market by Type
5.1 Global Apremilast Tablets Revenue by Type
5.1.1 Global Apremilast Tablets Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Apremilast Tablets Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Apremilast Tablets Revenue Market Share by Type (2020-2031)
5.2 Global Apremilast Tablets Sales by Type
5.2.1 Global Apremilast Tablets Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Apremilast Tablets Sales by Type (2020-2031) & (K Units)
5.2.3 Global Apremilast Tablets Sales Market Share by Type (2020-2031)
5.3 Global Apremilast Tablets Price by Type
6 Apremilast Tablets Market by Application
6.1 Global Apremilast Tablets Revenue by Application
6.1.1 Global Apremilast Tablets Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Apremilast Tablets Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Apremilast Tablets Revenue Market Share by Application (2020-2031)
6.2 Global Apremilast Tablets Sales by Application
6.2.1 Global Apremilast Tablets Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Apremilast Tablets Sales by Application (2020-2031) & (K Units)
6.2.3 Global Apremilast Tablets Sales Market Share by Application (2020-2031)
6.3 Global Apremilast Tablets Price by Application
7 Company Profiles
7.1 CSPC Ouyi Pharmaceutical
7.1.1 CSPC Ouyi Pharmaceutical Comapny Information
7.1.2 CSPC Ouyi Pharmaceutical Business Overview
7.1.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio
7.1.5 CSPC Ouyi Pharmaceutical Recent Developments
7.2 Shanghai Modern Pharmaceutical
7.2.1 Shanghai Modern Pharmaceutical Comapny Information
7.2.2 Shanghai Modern Pharmaceutical Business Overview
7.2.3 Shanghai Modern Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio
7.2.5 Shanghai Modern Pharmaceutical Recent Developments
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Comapny Information
7.3.2 Qilu Pharmaceutical Business Overview
7.3.3 Qilu Pharmaceutical Apremilast Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Qilu Pharmaceutical Apremilast Tablets Product Portfolio
7.3.5 Qilu Pharmaceutical Recent Developments
7.4 Glenmark Pharmaceuticals
7.4.1 Glenmark Pharmaceuticals Comapny Information
7.4.2 Glenmark Pharmaceuticals Business Overview
7.4.3 Glenmark Pharmaceuticals Apremilast Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio
7.4.5 Glenmark Pharmaceuticals Recent Developments
7.5 Amgen
7.5.1 Amgen Comapny Information
7.5.2 Amgen Business Overview
7.5.3 Amgen Apremilast Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Amgen Apremilast Tablets Product Portfolio
7.5.5 Amgen Recent Developments
8 North America
8.1 North America Apremilast Tablets Market Size by Type
8.1.1 North America Apremilast Tablets Revenue by Type (2020-2031)
8.1.2 North America Apremilast Tablets Sales by Type (2020-2031)
8.1.3 North America Apremilast Tablets Price by Type (2020-2031)
8.2 North America Apremilast Tablets Market Size by Application
8.2.1 North America Apremilast Tablets Revenue by Application (2020-2031)
8.2.2 North America Apremilast Tablets Sales by Application (2020-2031)
8.2.3 North America Apremilast Tablets Price by Application (2020-2031)
8.3 North America Apremilast Tablets Market Size by Country
8.3.1 North America Apremilast Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Apremilast Tablets Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Apremilast Tablets Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Apremilast Tablets Market Size by Type
9.1.1 Europe Apremilast Tablets Revenue by Type (2020-2031)
9.1.2 Europe Apremilast Tablets Sales by Type (2020-2031)
9.1.3 Europe Apremilast Tablets Price by Type (2020-2031)
9.2 Europe Apremilast Tablets Market Size by Application
9.2.1 Europe Apremilast Tablets Revenue by Application (2020-2031)
9.2.2 Europe Apremilast Tablets Sales by Application (2020-2031)
9.2.3 Europe Apremilast Tablets Price by Application (2020-2031)
9.3 Europe Apremilast Tablets Market Size by Country
9.3.1 Europe Apremilast Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Apremilast Tablets Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Apremilast Tablets Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Apremilast Tablets Market Size by Type
10.1.1 China Apremilast Tablets Revenue by Type (2020-2031)
10.1.2 China Apremilast Tablets Sales by Type (2020-2031)
10.1.3 China Apremilast Tablets Price by Type (2020-2031)
10.2 China Apremilast Tablets Market Size by Application
10.2.1 China Apremilast Tablets Revenue by Application (2020-2031)
10.2.2 China Apremilast Tablets Sales by Application (2020-2031)
10.2.3 China Apremilast Tablets Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Apremilast Tablets Market Size by Type
11.1.1 Asia Apremilast Tablets Revenue by Type (2020-2031)
11.1.2 Asia Apremilast Tablets Sales by Type (2020-2031)
11.1.3 Asia Apremilast Tablets Price by Type (2020-2031)
11.2 Asia Apremilast Tablets Market Size by Application
11.2.1 Asia Apremilast Tablets Revenue by Application (2020-2031)
11.2.2 Asia Apremilast Tablets Sales by Application (2020-2031)
11.2.3 Asia Apremilast Tablets Price by Application (2020-2031)
11.3 Asia Apremilast Tablets Market Size by Country
11.3.1 Asia Apremilast Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Apremilast Tablets Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Apremilast Tablets Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Apremilast Tablets Market Size by Type
12.1.1 SAMEA Apremilast Tablets Revenue by Type (2020-2031)
12.1.2 SAMEA Apremilast Tablets Sales by Type (2020-2031)
12.1.3 SAMEA Apremilast Tablets Price by Type (2020-2031)
12.2 SAMEA Apremilast Tablets Market Size by Application
12.2.1 SAMEA Apremilast Tablets Revenue by Application (2020-2031)
12.2.2 SAMEA Apremilast Tablets Sales by Application (2020-2031)
12.2.3 SAMEA Apremilast Tablets Price by Application (2020-2031)
12.3 SAMEA Apremilast Tablets Market Size by Country
12.3.1 SAMEA Apremilast Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Apremilast Tablets Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Apremilast Tablets Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Apremilast Tablets Value Chain Analysis
13.1.1 Apremilast Tablets Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Apremilast Tablets Production Mode & Process
13.2 Apremilast Tablets Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Apremilast Tablets Distributors
13.2.3 Apremilast Tablets Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.